Technical Analysis for CLIN - Clinigen Group Plc

Grade Last Price % Change Price Change
grade F 715.5 0.42% 3.00
CLIN closed up 0.42 percent on Friday, August 7, 2020, on 1.11 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Flat
Historical CLIN trend table...

Date Alert Name Type % Chg
Death Cross Bearish 0.00%
Lower Bollinger Band Touch Weakness 0.00%
NR7 Range Contraction 0.42%
20 DMA Resistance Bearish -0.63%
MACD Bullish Signal Line Cross Bullish -0.63%
20 DMA Resistance Bearish 1.42%
1,2,3 Retracement Bearish Bearish Swing Setup 1.42%
180 Bearish Setup Bearish Swing Setup 1.42%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.42%
1,2,3 Retracement Bearish Bearish Swing Setup -0.97%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Clinigen Group plc is a United Kingdom-based pharmaceutical and services company. The Company's principal activities include management, sale and distribution of pharmaceutical products, which have associated expiry dates. The Company operates through five segments: Clinigen Clinical Trial Services (CTS), which sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies; Idis Managed Access (MA), which is engaged in the consultancy, development, management and implementation of managed access programs for biotechnology and pharmaceutical companies; Idis Global Access (GA), which offers ethical access to post approval and short-supply medicines; Clinigen Specialty Pharmaceuticals (SP), which manufactures and distributes its own and in-licensed specialist, hospital-only medicines around the world, and Link Healthcare, which distributes pharmaceutical products in South Africa, and the Asia and Pacific region.
Articles Biotechnology Health Pharmaceutical Pharmaceutical Industry Clinical Trial Pharmaceutical Products Pharmaceutical Industry In China Pharmaceuticals Policy Clinical Research Medication Design Of Experiments

Is CLIN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1000.0
52 Week Low 350.4
Average Volume 348,781
200-Day Moving Average 785.35
50-Day Moving Average 784.85
20-Day Moving Average 728.28
10-Day Moving Average 716.05
Average True Range 41.98
ADX 31.28
+DI 12.62
-DI 27.09
Chandelier Exit (Long, 3 ATRs ) 680.05
Chandelier Exit (Short, 3 ATRs ) 770.45
Upper Bollinger Band 768.53
Lower Bollinger Band 688.02
Percent B (%b) 0.34
BandWidth 11.05
MACD Line -17.49
MACD Signal Line -18.45
MACD Histogram 0.9618
Fundamentals Value
Market Cap 657.74 Million
Num Shares 919 Thousand
EPS 6.30
Price-to-Earnings (P/E) Ratio 113.57
Price-to-Sales 349.05
Price-to-Book 314.47
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 812.25
Resistance 3 (R3) 804.67 764.83 796.13
Resistance 2 (R2) 764.83 740.19 768.63 790.75
Resistance 1 (R1) 740.17 724.97 752.50 747.75 785.37
Pivot Point 700.33 700.33 706.50 704.13 700.33
Support 1 (S1) 675.67 675.69 688.00 683.25 645.63
Support 2 (S2) 635.83 660.47 639.63 640.25
Support 3 (S3) 611.17 635.83 634.88
Support 4 (S4) 618.75